https://www.ndtvprofit.com/business/lupin-receives-usfda-nod-for-generic-eye-medication?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Lupin has obtained USFDA approval to market a generic eye medication, Loteprednol Etabonate ophthalmic suspension, 0.5%, for treating certain eye conditions.